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doi:10.1016/j.jtcvs.2003.11.051620 The Journal of Thoracic and CardioAneurysms of the thoracic aorta represent a potentially life-threat-ening situation, with the risk of rupture increasing with diameter.Surgical resection and interposition of vascular prostheses (Da-cron or polytetrafluoroethylene*) have long been considered thestandard treatment, despite the substantial risk of severe compli-cations from surgical trauma. Regardless of the great strides in the
past decades to improve technique and management, perioperative mortality and
morbidity remained high.1-3 As a consequence of demographic changes in the
Western world, the afflicted population is of increasing age and associated with a
variety of comorbidities portending an inherent risk and explaining in part the
sobering surgical outcomes. Moreover, perioperative complications ranging from
paraplegia to transient renal failure contribute to prolonged hospitalization and high
costs.4 As a revolutionary alternative,5 the concept of use of an endovascular stent
graft in a patient with a thoracic aortic aneurysm (TAA) emerged a decade ago
propelled by the desire (1) to avoid surgical risks by use of a nonsurgical approach
and (2) to induce reconstructive remodeling of the diseased aorta by initiating a
natural healing process through exclusion and depressurization of the aneurysmal
sac. Although initial reports on the endovascular stent-graft strategy were encour-
aging,6-8 randomized data on the use in TAA have not been produced yet, and the
smoldering critique has never been fully extinguished.
The article by Demers and colleagues9 is provocative and sobering at the same
time in its reflection on the late outcomes of 103 patients treated with custom-
fabricated endovascular stent grafts between 1992 and 1997 and followed over 4.5
 2.5 years. Patients considered unfit or not suitable for conventional surgical repair
had a 1- and 5-year survival of 74% 6% and 31% 6%, respectively; conversely,
patients considered fit even for conventional surgical intervention had a survival
after stent-graft placement of 93%  4% and 78%  6%, respectively (eg, patients
in better health condition fared significantly better). In other words, the health status
comprising age and comorbidities is the common denominator for prognosis and not
so much the less traumatic treatment concept of endovascular stent grafting.
On first sight, this conclusion is indeed sobering and, to a certain degree, even
trivial. Of course, the general state of health is highly important and should always
be part of strategic planning in medicine.10 Eventually, the observation by Demers
and colleagues9 documents the final emergence of the philosophical principle of
“nihil nocere” (a classic in medicine and surgery) in the brave new interventional
world. Demers and colleagues are to be congratulated for critically asking the
question of treating nonsurgical candidates at all because stent grafting seems to fail
to improve the outcomes of patients unfit for surgical intervention. On a closer look,
however, the design of a study comparing the outcomes of surgically fit with unfit
patients might leave room for speculation. An ideal study design would compare
outcomes of patients in similar health status subjected to either conventional
surgical intervention, to nonsurgical stent grafting, or to mere medical treatment. Of
course, the design of a prospective study is not feasible for ethical reasons (patients*Gore-Tex vascular prosthesis, registered trademark of W. L. Gore, Inc, Newark, Del.
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Lunfit for conventional surgery should of course not undergo
surgical intervention); on the other hand, the judgment of
unfitness for a major operation and thoracotomy has sub-
jective elements. Ideally, a comparison of natural history
with stent-graft placement in 2 groups of patients both
considered unfit for surgical intervention because of comor-
bidities in a prospective registry would best identify the
effect of the less traumatic endovascular strategy. These
considerations are well known at centers of surgical excel-
lence (such as Stanford), and it appears needless to say that
their careful and conservative conclusions deserve our re-
spect because they remember the nihil nocere principle. But
although Demers and colleagues found that those patients
deemed inoperable had a bleak outcome because of comor-
bidity and died primarily from medical diseases rather than
from aortic rupture and thus challenge the benefit of endo-
vascular stent grafting in cases of asymptomatic TAA, the
study is an eye opener in various ways.
First, patients considered in reasonable general health are
likely to have an outcome with stent grafting similar or
better to that with a conventional operation, and therefore
endovascular techniques might represent a true therapeutic
alternative for patients with TAA.
Second, patients with TAA and comorbidities are likely
to benefit from an appropriate vascular staging strategy to
objectively identify and quantify their risk. Staging should
include angiographic assessment of the individual cerebral,
coronary, and peripheral vasculature with optional catheter-
based revascularization or at least optimized medical treat-
ment with -blockers, both of which are likely to improve
the general health status and thus perioperative outcomes.
Third, miniaturization and refinement of endovascular
technology is certainly advancing. Endoaortic interventions
will soon be performed percutaneously during local anes-
thesia, and more physiologic stent grafts will mimic even
the rotational 3-dimensional systolic twist of the thoracic
aorta, whereas contemporary surgical techniques in TAA
are less likely to improve.11-14 More importantly, even
successful aortic surgery will not abolish any of the asso-
ciated risk factors from comorbid conditions, and therefore
late outcome will remain dominated by the individual prog-
nosis (comorbid state). As a consequence, in centers of
excellence for aortic disease, the endovascular treatment
options are more likely to prevail, even in highly comorbid
subsets of patients, because at least the surgical risk will be
eliminated with endovascular techniques.
Finally, a new answer to the ethical question of justifi-
cation of treatment is not in yet because prospective data
from randomized studies or registries are not available norThe Journal of Thoraciare standard operational procedures or guidelines. However,
if one insists on strict proof (or strict disproof) in empiric
science, one will never benefit from experience and never
learn from it how wrong one has been.15 Nevertheless, even
in a world of rapidly advancing technology, it is ironically
still wise to remember old principles of responsible use of
clinical judgment and experience for the benefit of our
patients. The growing segment of older patients with mul-
tiorgan comorbidities deserve a holistic approach, the intel-
ligent use of prognosticating tools, and close interdiscipli-
nary cooperation in a medicoethical framework.16
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